Marr Kieren, Phan Phillip
Department of Medicine, Johns Hopkins Medicine, 1800 Orleans St., Baltimore, MD 21287 USA.
Carey Business School, Johns Hopkins University, 100 International Drive, Baltimore, MD 21202 USA.
J Technol Transf. 2020;45(6):1823-1841. doi: 10.1007/s10961-020-09827-0. Epub 2020 Sep 23.
Turning university research output into useful products such as drugs, devices and diagnostics requires skills, knowledge, and resources traditionally attributed to private industry. When it comes to intangibles such as care delivery models, informatics and algorithms, and the software behind smart wearables, the commercialization challenges are even greater. With notable exceptions, Academic Medical Centers have typically not excelled in advancing commercialization of such non-patent intellectual property (IP). We believe that this is in part because the traditional closed form university IP policy, formulated since Bayh-Dole (1980), is ill-suited to non-patent IP. In this paper, we reflect on the evolving challenges that new forms of healthcare-related discoveries, specifically non-patent IP, are placing on the traditional university intellectual property and technology transfer regime, and to offer suggestions on how universities can begin to modernize their IP policies to support the valorization of non-patent IP.
将大学的研究成果转化为药物、设备和诊断等有用产品，需要具备传统上归属于私营企业的技能、知识和资源。对于诸如护理交付模式、信息学和算法以及智能可穿戴设备背后的软件等无形资产而言，商业化挑战甚至更大。除了少数显著的例外情况，学术医疗中心在推进此类非专利知识产权（IP）的商业化方面通常表现不佳。我们认为，部分原因在于自《拜杜法案》（1980年）以来制定的传统封闭式大学知识产权政策并不适合非专利知识产权。在本文中，我们思考了与医疗保健相关的新形式发现，特别是非专利知识产权，给传统大学知识产权和技术转让制度带来的不断演变的挑战，并就大学如何开始使其知识产权政策现代化以支持非专利知识产权的增值提出建议。
